ADAMTS-13 mutant
US8685665B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 19, 2008 |
| Grant date | Apr 1, 2014 |
| Priority date | — |
| Expiry date | Jul 5, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/24087
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of enhancing an enzymatic activity of a disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) by substituting on or more positions in the isolated human ADAMTS-13.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.